Catalyst Event

Merck and Co Inc (MRK) · Other

From Akros U.S. Tech 100 Protective Allocation Monthly Index (A100PAM)

4/24/2026, 12:00:00 AM

OtherSentiment: Positive

Merck announced on April 24, 2026, that the Hart-Scott-Rodino antitrust waiting period expired for its pending acquisition of Terns Pharmaceuticals, satisfying a key condition for the ~$6.7 billion deal to bolster its oncology pipeline.

Korean Translation

머크(Merck), 2026년 4월 24일 턴스 파마슈티컬스(Terns Pharmaceuticals) 인수를 위한 하트-스코트-로디노(Hart-Scott-Rodino) 반독점 대기 기간이 만료되었다고 발표함. 이는 항암 파이프라인 강화를 위한 약 67억 달러 규모 거래의 핵심 조건을 충족시킨 것임.

Related Recent Events

View Full Timeline